Hayden Michael R
Insider CIK 1352908 · XENE Director · AUPH Director · ABCL Director · ETNB Director · IONS Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ABCL AbCellera Biologics Inc. | P Buy | 2026-08-24 | 2026-08-24 | 53,613 | $10.64 | $570.4K | 1,373,397 | SEC↗ |
| ABCL AbCellera Biologics Inc. | P Buy | 2026-08-24 | 2026-08-24 | 53,613 | $10.64 | $570.4K | 1,373,397 | SEC↗ |
| ABCL AbCellera Biologics Inc. | P Buy | 2026-08-12 | 2026-08-14 | 46,387 | $10.37 | $481.0K | 1,319,784 | SEC↗ |
| ABCL AbCellera Biologics Inc. | P Buy | 2026-08-12 | 2026-08-14 | 46,387 | $10.37 | $481.0K | 1,319,784 | SEC↗ |
| ABCL AbCellera Biologics Inc. | G Gift | 2026-08-11 | 2026-08-13 | 50,000 | — | $0 | 1,273,397 | SEC↗ |
| ABCL AbCellera Biologics Inc. | G Gift | 2026-08-11 | 2026-08-13 | 50,000 | — | $0 | 1,273,397 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | P Buy | 2026-07-31 | 2026-07-31 | 5,000 | $51.60 | $258.0K | 24,000 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | P Buy | 2026-07-31 | 2026-07-31 | 5,000 | $51.60 | $258.0K | 24,000 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | P Buy | 2026-07-30 | 2026-07-31 | 15,000 | $53.38 | $800.7K | 19,000 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | P Buy | 2026-07-30 | 2026-07-31 | 15,000 | $53.38 | $800.7K | 19,000 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | A Award deriv | 2026-07-01 | 2026-07-06 | 2,301 | — | $0 | 12,198 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | A Award deriv | 2026-07-01 | 2026-07-06 | 5,369 | — | $0 | 5,369 | SEC↗ |
| ABCL AbCellera Biologics Inc. | A Award deriv | 2026-06-11 | 2026-06-12 | 111,701 | — | $0 | 1,011,544 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-10-30 | 45,150 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-10-30 | 22,730 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-10-30 | 2,933 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-10-30 | 7,000 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-10-30 | 7,000 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-10-30 | 12,500 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-10-30 | 25,000 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-10-30 | 27,400 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-10-30 | 56,400 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | D To issuer deriv | 2025-10-30 | 2025-10-30 | 27,647 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | U Tender | 2025-10-30 | 2025-10-30 | 103,978 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | U Tender | 2025-10-30 | 2025-10-30 | 61,538 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | U Tender | 2025-10-30 | 2025-10-30 | 80,904 | — | $0 | 0 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise deriv | 2025-07-15 | 2025-07-17 | 4,079 | — | $0 | 9,897 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise | 2025-07-15 | 2025-07-17 | 4,079 | — | $0 | 54,298 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | A Award deriv | 2025-07-01 | 2025-07-02 | 5,220 | — | $0 | 13,976 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | A Award deriv | 2025-07-01 | 2025-07-02 | 11,518 | — | $0 | 11,518 | SEC↗ |
| ABCL AbCellera Biologics Inc. | A Award deriv | 2025-06-12 | 2025-07-01 | 238,864 | — | $0 | 899,843 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | P Buy | 2025-05-01 | 2025-05-02 | 15,000 | $31.86 | $477.9K | 50,219 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2025-02-03 | 2025-02-05 | 56,400 | — | $0 | 56,400 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | P Buy | 2024-12-23 | 2024-12-26 | 2,500 | $36.20 | $90.5K | 32,719 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | P Buy | 2024-12-23 | 2024-12-26 | 2,500 | $36.23 | $90.6K | 35,219 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | A Award deriv | 2024-07-01 | 2024-07-03 | 4,079 | — | $0 | 8,756 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | A Award deriv | 2024-07-01 | 2024-07-03 | 10,111 | — | $0 | 10,111 | SEC↗ |
| ABCL AbCellera Biologics Inc. | A Award deriv | 2024-06-21 | 2024-06-24 | 163,934 | — | $0 | 660,979 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2024-02-01 | 2024-02-05 | 45,150 | — | $0 | 45,150 | SEC↗ |
| ABCL AbCellera Biologics Inc. | P Buy | 2023-09-22 | 2023-09-26 | 20,000 | $4.91 | $98.2K | 1,323,397 | SEC↗ |
| ABCL AbCellera Biologics Inc. | P Buy | 2023-08-08 | 2023-08-09 | 30,000 | $5.90 | $177.0K | 1,303,397 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise deriv | 2023-07-17 | 2023-07-19 | 5,333 | — | $0 | 4,677 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise deriv | 2023-07-17 | 2023-07-19 | 1,777 | — | $0 | 10,010 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise | 2023-07-17 | 2023-07-19 | 5,333 | — | $0 | 30,219 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise | 2023-07-17 | 2023-07-19 | 1,777 | — | $0 | 24,886 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | A Award deriv | 2023-07-03 | 2023-07-06 | 4,677 | — | $0 | 11,787 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | A Award deriv | 2023-07-03 | 2023-07-06 | 10,321 | — | $0 | 10,321 | SEC↗ |
| ETNB 89bio, Inc. | P Buy | 2023-03-28 | 2023-03-30 | 61,538 | $16.15 | $993.8K | 61,538 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2023-02-09 | 2023-02-13 | 27,400 | — | $0 | 27,400 | SEC↗ |
| ABCL AbCellera Biologics Inc. | A Award deriv | 2022-12-01 | 2022-12-05 | 47,231 | — | $0 | 497,045 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise deriv | 2022-10-17 | 2022-10-18 | 1,777 | — | $0 | 7,110 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise | 2022-10-17 | 2022-10-18 | 1,777 | — | $0 | 23,109 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise deriv | 2022-07-15 | 2022-07-19 | 1,777 | — | $0 | 8,887 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise deriv | 2022-07-15 | 2022-07-19 | 5,333 | — | $0 | 10,664 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise | 2022-07-15 | 2022-07-19 | 1,777 | — | $0 | 21,332 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise | 2022-07-15 | 2022-07-19 | 5,333 | — | $0 | 19,555 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | A Award deriv | 2022-07-01 | 2022-07-06 | 5,333 | — | $0 | 15,997 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | A Award deriv | 2022-07-01 | 2022-07-06 | 12,000 | — | $0 | 12,000 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2022-05-16 | 2022-05-18 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ETNB 89bio, Inc. | P Buy | 2022-04-25 | 2023-03-30 | 10,000 | $2.67 | $26.7K | 103,978 | SEC↗ |
| ETNB 89bio, Inc. | P Buy | 2022-04-07 | 2023-03-30 | 10,000 | $3.48 | $34.8K | 93,978 | SEC↗ |
| ETNB 89bio, Inc. | P Buy | 2022-03-30 | 2023-03-30 | 6,250 | $3.62 | $22.6K | 83,978 | SEC↗ |
| ABCL AbCellera Biologics Inc. | A Award deriv | 2021-12-07 | 2021-12-10 | 45,532 | — | $0 | 449,814 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise deriv | 2021-10-15 | 2021-10-19 | 1,777 | — | $0 | 10,664 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise | 2021-10-15 | 2021-10-19 | 1,777 | — | $0 | 14,222 | SEC↗ |
| ABCL AbCellera Biologics Inc. | M Exercise deriv | 2021-09-13 | 2021-09-15 | 270,000 | — | $0 | 270,000 | SEC↗ |
| ABCL AbCellera Biologics Inc. | M Exercise | 2021-09-13 | 2021-09-15 | 270,000 | $17.73 | $4.79M | 1,273,397 | SEC↗ |
| ABCL AbCellera Biologics Inc. | A Award deriv | 2021-08-27 | 2021-12-10 | 34,282 | — | $0 | 674,282 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise deriv | 2021-07-15 | 2021-07-19 | 1,778 | — | $0 | 12,441 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise deriv | 2021-07-15 | 2021-07-19 | 5,333 | — | $0 | 14,219 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise | 2021-07-15 | 2021-07-19 | 1,778 | — | $0 | 12,445 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise | 2021-07-15 | 2021-07-19 | 5,333 | — | $0 | 10,667 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | A Award deriv | 2021-07-01 | 2021-07-06 | 12,000 | — | $0 | 12,000 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | A Award deriv | 2021-07-01 | 2021-07-06 | 5,333 | — | $0 | 19,552 | SEC↗ |
| ABCL AbCellera Biologics Inc. | S Sale | 2021-06-22 | 2021-06-22 | 100,000 | $25.50 | $2.55M | 1,003,397 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2021-06-03 | 2021-06-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2021-05-18 | 2021-05-20 | 3,500 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2021-05-18 | 2021-05-20 | 3,500 | $3.85 | $13.5K | 116,206 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2021-04-15 | 2021-04-19 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ETNB 89bio, Inc. | M Exercise deriv | 2021-02-23 | 2021-02-25 | 13,637 | — | $0 | 22,730 | SEC↗ |
| ETNB 89bio, Inc. | M Exercise deriv | 2021-02-23 | 2021-02-25 | 6,447 | — | $0 | 2,933 | SEC↗ |
| ETNB 89bio, Inc. | M Exercise deriv | 2021-02-23 | 2021-02-25 | 60,820 | — | $0 | 27,647 | SEC↗ |
| ETNB 89bio, Inc. | M Exercise | 2021-02-23 | 2021-02-25 | 13,637 | $3.11 | $42.4K | 80,904 | SEC↗ |
| ETNB 89bio, Inc. | M Exercise | 2021-02-23 | 2021-02-25 | 6,447 | $1.93 | $12.4K | 67,267 | SEC↗ |
| ETNB 89bio, Inc. | M Exercise | 2021-02-23 | 2021-02-25 | 60,820 | $1.93 | $117.4K | 60,820 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2021-02-18 | 2021-02-18 | 10,288 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2021-02-18 | 2021-02-18 | 30,864 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2021-02-18 | 2021-02-18 | 10,288 | $3.67 | $37.8K | 61,212 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2021-02-18 | 2021-02-18 | 30,864 | $2.68 | $82.7K | 92,076 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2021-02-16 | 2021-02-18 | 5,144 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2021-02-16 | 2021-02-18 | 5,144 | $2.68 | $13.8K | 112,706 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | M Exercise deriv | 2021-01-29 | 2021-02-02 | 50,000 | — | $0 | 0 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | M Exercise deriv | 2021-01-29 | 2021-02-02 | 15,000 | — | $0 | 0 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | M Exercise deriv | 2021-01-29 | 2021-02-02 | 30,000 | — | $0 | 0 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | M Exercise | 2021-01-29 | 2021-02-02 | 15,000 | $6.42 | $96.3K | 95,000 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | M Exercise | 2021-01-29 | 2021-02-02 | 50,000 | $5.44 | $272.0K | 50,000 | SEC↗ |
| AUPH Aurinia Pharmaceuticals In | M Exercise | 2021-01-29 | 2021-02-02 | 30,000 | $6.06 | $181.8K | 80,000 | SEC↗ |
| ABCL AbCellera Biologics Inc. | C Conversion deriv | 2020-12-15 | 2020-12-17 | 0 | — | $0 | 0 | SEC↗ |
| ABCL AbCellera Biologics Inc. | P Buy | 2020-12-15 | 2020-12-17 | 73,665 | $20.00 | $1.47M | 118,245 | SEC↗ |
| ABCL AbCellera Biologics Inc. | C Conversion | 2020-12-15 | 2020-12-17 | 117,647 | — | $0 | 1,103,397 | SEC↗ |
| ABCL AbCellera Biologics Inc. | A Award deriv | 2020-12-11 | 2020-12-17 | 0 | $2000000.00 | $0 | 0 | SEC↗ |
| ABCL AbCellera Biologics Inc. | A Award deriv | 2020-11-18 | 2020-12-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ABCL AbCellera Biologics Inc. | M Exercise deriv | 2020-11-06 | 2020-12-17 | 270,000 | — | $0 | 540,000 | SEC↗ |
| ABCL AbCellera Biologics Inc. | M Exercise | 2020-11-06 | 2020-12-17 | 270,000 | $0.33 | $89.1K | 985,750 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise deriv | 2020-10-15 | 2020-10-19 | 1,778 | — | $0 | 3,554 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise | 2020-10-15 | 2020-10-19 | 1,778 | — | $0 | 5,334 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | A Award deriv | 2020-07-01 | 2020-07-06 | 12,000 | — | $0 | 12,000 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | A Award deriv | 2020-07-01 | 2020-07-06 | 5,333 | — | $0 | 5,333 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise deriv | 2020-07-01 | 2020-07-06 | 1,778 | — | $0 | 5,332 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise | 2020-07-01 | 2020-07-06 | 1,778 | — | $0 | 3,556 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2020-06-22 | 2020-07-14 | 7,000 | — | $0 | 7,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2020-06-01 | 2020-06-02 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ETNB 89bio, Inc. | A Award deriv | 2020-04-05 | 2020-04-07 | 7,000 | — | $0 | 7,000 | SEC↗ |
| ETNB 89bio, Inc. | C Conversion deriv | 2019-11-13 | 2019-11-13 | 366,667 | — | $0 | 0 | SEC↗ |
| ETNB 89bio, Inc. | C Conversion | 2019-11-13 | 2019-11-13 | 58,978 | — | $0 | 77,728 | SEC↗ |
| ETNB 89bio, Inc. | P Buy | 2019-11-11 | 2019-11-13 | 18,750 | $16.00 | $300.0K | 18,750 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise deriv | 2019-10-15 | 2019-10-17 | 1,778 | — | $0 | 5,332 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | M Exercise | 2019-10-15 | 2019-10-17 | 1,778 | — | $0 | 1,778 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2019-09-16 | 2019-09-18 | 15,000 | — | $0 | 15,000 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | A Award deriv | 2019-07-01 | 2019-07-03 | 7,110 | — | $0 | 7,110 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | A Award deriv | 2019-07-01 | 2019-07-03 | 16,000 | — | $0 | 16,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2019-03-19 | 2019-03-20 | 20,576 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2019-03-19 | 2019-03-20 | 20,576 | $3.38 | $69.5K | 50,924 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | G Gift | 2019-03-11 | 2019-03-12 | 24,045 | — | $0 | 107,562 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | G Gift | 2019-03-11 | 2019-03-12 | 17,337 | — | $0 | 114,403 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | A Award deriv | 2018-10-15 | 2018-10-15 | 7,110 | — | $0 | 7,110 | SEC↗ |
| IONS IONIS PHARMACEUTICALS INC | A Award deriv | 2018-09-20 | 2018-09-24 | 32,000 | — | $0 | 32,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2018-06-04 | 2018-06-05 | 15,000 | — | $0 | 15,000 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | G Gift | 2018-02-22 | 2018-03-01 | 21,180 | — | $0 | 97,066 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | G Gift | 2018-02-22 | 2018-03-01 | 29,580 | — | $0 | 131,607 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | P Buy | 2017-08-14 | 2017-08-14 | 15,000 | $2.75 | $41.3K | 161,187 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2017-06-01 | 2017-06-02 | 3,500 | — | $0 | 3,500 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2017-03-14 | 2017-03-15 | 3,086 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2017-03-14 | 2017-03-15 | 4,115 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2017-03-14 | 2017-03-15 | 5,144 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2017-03-14 | 2017-03-15 | 25,720 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2017-03-14 | 2017-03-15 | 18,004 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2017-03-14 | 2017-03-15 | 4,629 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2017-03-14 | 2017-03-15 | 4,629 | $3.07 | $14.2K | 27,262 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2017-03-14 | 2017-03-15 | 18,004 | $3.70 | $66.6K | 115,323 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2017-03-14 | 2017-03-15 | 25,720 | $3.76 | $96.7K | 141,043 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2017-03-14 | 2017-03-15 | 3,086 | $3.56 | $11.0K | 30,348 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2017-03-14 | 2017-03-15 | 4,115 | $3.77 | $15.5K | 22,633 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2017-03-14 | 2017-03-15 | 5,144 | $3.67 | $18.9K | 146,187 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2016-06-02 | 2016-06-03 | 3,500 | — | $0 | 3,500 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2016-05-25 | 2016-05-27 | 8,230 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2016-05-25 | 2016-05-27 | 8,230 | $3.30 | $27.2K | 18,518 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2015-05-04 | 2015-05-06 | 3,086 | — | $0 | 3,086 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2015-02-03 | 2015-02-05 | 5,144 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2015-02-03 | 2015-02-05 | 5,144 | $4.81 | $24.7K | 10,288 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise deriv | 2015-01-08 | 2015-01-12 | 5,144 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | M Exercise | 2015-01-08 | 2015-01-12 | 5,144 | $4.98 | $25.6K | 5,144 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | C Conversion deriv | 2014-11-09 | 2014-11-12 | 1,504 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | C Conversion deriv | 2014-11-09 | 2014-11-12 | 2,693 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | C Conversion deriv | 2014-11-09 | 2014-11-12 | 10,030 | — | $0 | 0 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | C Conversion | 2014-11-09 | 2014-11-12 | 2,693 | — | $0 | 74,382 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | C Conversion | 2014-11-09 | 2014-11-12 | 10,030 | — | $0 | 71,689 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | C Conversion | 2014-11-09 | 2014-11-12 | 1,504 | — | $0 | 75,886 | SEC↗ |
| XENE Xenon Pharmaceuticals Inc. | A Award deriv | 2014-11-04 | 2014-11-06 | 5,144 | — | $0 | 5,144 | SEC↗ |